GlassScriptPhysician profile
Bethany Rowell
NPI 1528894169
$2,698.83
in general payments reported to CMS, 2019-2025
13 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,670 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,600 · Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,600.00 |
| Food and Beverage | $1,098.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,638.09 | 2024-2025 | Venacure 1470 Pro, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.08 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $254.53 | 2024-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $194.18 | 2025 | Ozempic |
| Novartis Pharmaceuticals Corporation | $105.98 | 2025 | |
| Pfizer INC. | $87.07 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $49.16 | 2024-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $23.26 | 2025 | Camzyos |
| Boston Scientific Corporation | $20.66 | 2025 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2025 | Jardiance |
| Recor Medical INC | $18.33 | 2025 | Paradise Ultrasound Renal Denervation System |
| Lilly USA, LLC | $14.54 | 2025 | Zepbound |
| Amgen INC. | $14.02 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Rowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.